Evidence map›Paper›PMID 30732596›Full record

ArticleMicrobial cell factories2019

Tailoring the properties of (catalytically)-active inclusion bodies.

V D Jäger, R Kloss, A Grünberger, S Seide, D Hahn, T Karmainski, M Piqueray, J Embruch, S Longerich, U Mackfeld and 4 more

Abstract read
In one paragraph

Article in Microbial cell factories, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Expression Patterns and Functional Analysis of ThreeInternational journal of molecular sciences · 2023
    Article
  7. Recombinant protein condensation insideMaterials today. Bio · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Coiled-Coil Based Inclusion Bodies and Their Potential Applications.Frontiers in bioengineering and biotechnology · 2021
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

V D JägerInstitut für Molekulare Enzymtechnologie, Heinrich-Heine-Universität Düsseldorf, Forschungszentrum Jülich, 52425, Jülich, Germany.
R KlossIBG-1: Biotechnology, Forschungszentrum Jülich GmbH, 52425, Jülich, Germany.
A GrünbergerIBG-1: Biotechnology, Forschungszentrum Jülich GmbH, 52425, Jülich, Germany.
S SeideIBG-1: Biotechnology, Forschungszentrum Jülich GmbH, 52425, Jülich, Germany.
D HahnIBG-1: Biotechnology, Forschungszentrum Jülich GmbH, 52425, Jülich, Germany.
T KarmainskiIBG-1: Biotechnology, Forschungszentrum Jülich GmbH, 52425, Jülich, Germany.
M PiquerayInstitut für Molekulare Enzymtechnologie, Heinrich-Heine-Universität Düsseldorf, Forschungszentrum Jülich, 52425, Jülich, Germany.
J EmbruchIBG-1: Biotechnology, Forschungszentrum Jülich GmbH, 52425, Jülich, Germany.
S LongerichInstitut für Molekulare Enzymtechnologie, Heinrich-Heine-Universität Düsseldorf, Forschungszentrum Jülich, 52425, Jülich, Germany.
U MackfeldIBG-1: Biotechnology, Forschungszentrum Jülich GmbH, 52425, Jülich, Germany.
K-E JaegerInstitut für Molekulare Enzymtechnologie, Heinrich-Heine-Universität Düsseldorf, Forschungszentrum Jülich, 52425, Jülich, Germany.
W WiechertIBG-1: Biotechnology, Forschungszentrum Jülich GmbH, 52425, Jülich, Germany.
M PohlIBG-1: Biotechnology, Forschungszentrum Jülich GmbH, 52425, Jülich, Germany.
U KraussInstitut für Molekulare Enzymtechnologie, Heinrich-Heine-Universität Düsseldorf, Forschungszentrum Jülich, 52425, Jülich, Germany. u.krauss@fz-juelich.de.ORCID http://orcid.org/0000-0003-2219-7388

Funding

Ministerium für Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen (DE) NRW Strategieprojekt BioSC: 313/323-400-002 13
6 · The paper itself

Abstract

backgroundImmobilization is an appropriate tool to ease the handling and recycling of enzymes in biocatalytic processes and to increase their stability. Most of the established immobilization methods require case-to-case optimization, which is laborious and time-consuming. Often, (chromatographic) enzyme purification is required and stable immobilization usually includes additional cross-linking or adsorption steps. We have previously shown in a few case studies that the molecular biological fusion of an aggregation-inducing tag to a target protein induces the intracellular formation of protein aggregates, so called inclusion bodies (IBs), which to a certain degree retain their (catalytic) function. This enables the combination of protein production and immobilization in one step. Hence, those biologically-produced immobilizates were named catalytically-active inclusion bodies (CatIBs) or, in case of proteins without catalytic activity, functional IBs (FIBs). While this strategy has been proven successful, the efficiency, the potential for optimization and important CatIB/FIB properties like yield, activity and morphology have not been investigated systematically.

resultsWe here evaluated a CatIB/FIB toolbox of different enzymes and proteins. Different optimization strategies, like linker deletion, C- versus N-terminal fusion and the fusion of alternative aggregation-inducing tags were evaluated. The obtained CatIBs/FIBs varied with respect to formation efficiency, yield, composition and residual activity, which could be correlated to differences in their morphology; as revealed by (electron) microscopy. Last but not least, we demonstrate that the CatIB/FIB formation efficiency appears to be correlated to the solvent-accessible hydrophobic surface area of the target protein, providing a structure-based rationale for our strategy and opening up the possibility to predict its efficiency for any given target protein.

conclusionWe here provide evidence for the general applicability, predictability and flexibility of the CatIB/FIB immobilization strategy, highlighting the application potential of CatIB-based enzyme immobilizates for synthetic chemistry, biocatalysis and industry.

Indexed as

BiocatalysisEnzymes, ImmobilizedEscherichia coliHydrophobic and Hydrophilic InteractionsInclusion BodiesIndustrial MicrobiologyProtein AggregatesProtein EngineeringStructure-Activity RelationshipEnzymes, ImmobilizedProtein AggregatesBiocatalysisEnzymesImmobilizationInclusion bodiesProtein aggregatesProtein engineeringStructure–function relations

Identifiers

PMID30732596
PMCPMC6367779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.